AKASA Funding, Investors & Competitors

AKASA has raised $205M across 4 funding rounds, most recently a $120M Series C in June 2024.

See full AKASA profile

Last AKASA funding round

$120M

Series C · Jun 2024

Cumulative funding AKASA raised

$205M

across 4 funding rounds

Key investors in AKASA

  • Andreessen Horowitz
  • Costanoa Ventures
  • Bond
  • Refactor
  • Olive Capital
  • Nancy Xiao

AKASA Overview

About AKASA

AKASA is a San Francisco-headquartered developer of AI-driven revenue cycle automation for healthcare providers. The platform handles prior authorizations, claims processing, and denial management using large language models. Backed by over $200 million from Andreessen Horowitz and others, AKASA serves U.S. hospitals reducing accounts receivable days through integrations with major EHR systems.


Founded

2018

HQ

United StatesSan Francisco, CA

Website

akasa.com

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

AKASA Funding History

AKASA has raised a total of $205M across 4 funding rounds.

AKASA's first fundraising round was a $5M seed round in January 2019. The most recent completed round was a $120M Series C in June 2024.

AKASA funding rounds

AKASA funding rounds
DateStageInvestorsRaisedDeal Summary
Jun 2024Series C-$120MAKASA is a San Francisco-based provider of AI solutions for healthcare revenue cycle management, automating processes to address challenges like rising volumes and staffing shortages. AKASA focuses on healthcare finance issues through automation. On June 18, 2024, AKASA raised $120 million in its Series C funding round, bringing total funding to $205 million. Investors included Andreessen Horowitz, Costanoa Ventures, and Bond. The funds aim to enhance its AI-driven platform integrating technology with expert revenue cycle management.
Mar 2021Series BBond (lead); Nancy Xiao (lead); Andreessen Horowitz; Costanoa Ventures$60M-
Jun 2020Series AAndreessen Horowitz (lead); Costanoa Ventures$20MAKASA (previously Alpha Health) develops an AI-powered platform that automates the end-to-end revenue cycle for healthcare providers, focusing on financial clearance, billing, and claims processing to reduce administrative costs, which account for $0.25 per $1 of hospital revenue collected. The company was founded by Malinka Walaliyadde, Varun Ganapathi, Andy Atwal, and Ben Beadle-Ryby, with expertise from revenue cycle operations at The Advisory Board Company and Counsyl, and AI from Stanford, Google, and Udacity. The platform targets back-office inefficiencies in healthcare to deliver cost savings and efficiency in provider payments without requiring operational overhauls. Andreessen Horowitz led AKASA's Series A round on approximately June 10, 2020, following a Seed VC round on December 24, 2019; both involved Andreessen Horowitz. Costanoa Ventures is listed among AKASA's investors. AKASA continued raising capital post-Series A, including a Series B on March 23, 2021 (Andreessen Horowitz) and Series C for $120M on June 18, 2024, bringing total funding to $205M over four rounds from four investors including Bond and Jim Momtazee.
Jan 2019SeedAndreessen Horowitz (lead); Olive Capital; Refactor; Costanoa Ventures$5M-

Who has invested in AKASA?

6 investors have backed AKASA across its funding rounds, including Andreessen Horowitz, Costanoa Ventures, Bond, Refactor, Olive Capital and Nancy Xiao.

Lead investors include Bond, Nancy Xiao and Andreessen Horowitz.


AKASA Investors

Investors in AKASA by funding rounds participated
InvestorHQRoundsRoleFirst check
Andreessen HorowitzUnited StatesSan Francisco, CA3LeadJan 2019
Costanoa VenturesUnited StatesSan Francisco, CA3ParticipantJan 2019
Olive CapitalUnited StatesSan Francisco, CA1ParticipantJan 2019
RefactorUnited StatesSan Francisco, CA1ParticipantJan 2019

This data is available for Pro users. Sign up to see all 6 AKASA investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

AKASA Competitors

AKASA competitors include listed companies like Waystar, Craneware and IQVIA, and private ones like Hippocratic AI, Commure and Abridge.

Public and private companies comparable to AKASA
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Hippocratic AIUnited StatesSan Francisco, CAPrivate--$3.5B-
WaystarUnited StatesUnited StatesPublicly listed$1.1B$390M$5.1B5.2x
CranewareUnited KingdomUnited KingdomPublicly listed$206M$59M$589M2.7x
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
AbridgeUnited StatesPittsburgh, PAPrivate$117M-$5.3B45.3x
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x

AKASA Public Comps

AKASA is still privately-owned, but its public comps include Palantir, Snowflake, Z.ai, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, Tenet Healthcare and IonQ.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Palantir$4.5B$1.5B92.6x58.1x285.0x97.4x
Snowflake$4.7B($1.3B)25.6x21.0x(94.1x)121.7x
Z.ai$108M($658M)422.9x65.9x(69.4x)(73.0x)
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x

This data is available for Pro users. Sign up to see all AKASA competitors and their valuation data.

Start Free Trial

Common questions about AKASA

When was AKASA founded?AKASA was founded in 2018.
Where is AKASA headquartered?AKASA is headquartered in San Francisco, CA, United States.
Is AKASA publicly listed?No, AKASA is a private, VC-backed company.
How much funding has AKASA raised?AKASA has raised $205M across 4 funding rounds.
What was AKASA's last funding round?AKASA's last funding round was a $120M Series C in June 2024.
Who are AKASA's investors?AKASA's investors include Andreessen Horowitz, Costanoa Ventures, Olive Capital, Refactor, Nancy Xiao and Bond.
Which companies are comparable to AKASA?Companies comparable to AKASA include Hippocratic AI, Waystar, Craneware, Commure, Abridge and IQVIA.

See companies similar to AKASA

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial